Destiny Pharma Share Discussion Threads

[jonwig] 08/9/2017 17:50

I saw the initial RNS and looked at the website. Basically their compounds appear to act so quickly that bacteria have no time to develop resistance via mutation.

My immediate reaction to this was extreme scepticism. It appears to suggest that antibiotic resistant mutations happen when bacteria are stimulated by exposure to an agent. But this isn't the case: they happen purely randomly. Indeed there will already exist resistant strains, and resistant populations will develop and increase by natural selection as happens with current antibiotics. I met a biochemist last week (on holiday) whose discipline is immunology, so not quite the same, and he confirmed that my general understanding was correct.

Obviously I need to do more study on this and it would be good to see if the company's research has been peer-reviewed. (A lot of these companies don't allow that.) I know their early trials have been successful, and I may be off-beam here, but I wouldn't want to invest in anything I didn't understand.

[kipper1960] 06/9/2017 16:55

Hi Mod, Bamboo. I'd like to join the discussion if I may? I am a pre-IPO holder of DEST - invested in one the fundraising rounds back in 2013. So far so good!

[modform] 05/9/2017 21:00

It was purely on a recommendation of a friend, it's a small gamble so happy to run with it.I am still very much upbeat about the market, my view is that the bull market will continue with some minor corrections along the way.

[modform] 05/9/2017 20:02

Cheers bamboo, hope you're on board